TechConnect Summit 2011

Treatment of Influenza Virus-Mediated Lung Injury: Blocking the A1-Adenosine Receptor

Organization:The Ohio State University, Ohio, US
I.P. Brief:A US provisional patent application, filed July 23, 2010, is pending. Foreign rights are available. The specification covers use of all A1-adenosine receptor antagonists to fill a serious market gap: treatment of influenza-induced lung injury, without requiring annual reformulation (vaccines) or development of drug resistance (antivirals).
Keywords:Influenza, acute lung injury, A1-adenosine receptor antagonists, ARDS, pulmonary edema, hypoxemia, pandemic
Primary Industry:Pharmaceuticals

Full IP Descriptions available on-site.


 

TechConnect World 2011 Nanotech 2011 Clean Technology 2011 Microtech 2011 BioNanotech 2011 TechConnect Summit 2011
Program | Exhibit/Sponsor | Press | Venue | Register
Short Courses | News | Subscribe | Contact | Site Map
© Copyright 2010 TechConnect World. All Rights Reserved.